Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank38
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-60.06M
↓ 16% vs avg
Percentile
P38
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-51.62M
Historical baseline
PeriodValueYoY Change
TTM$-60.06M-2608.1%
2024$-2.22M+97.6%
2023$-90.97M+6.3%
2022$-97.05M-23.7%
2021$-78.48M-46.3%
2020$-53.66M-35.9%
2019$-39.48M-75.0%
2018$-22.56M-12.4%
2017$-20.07M-